![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Monday, August 03, 2020 8:33:58 AM
I think everyone needs to understand what we’re essentially betting on with RVV in terms of the “covid play” (I actually entered my position as a shroom play, but now this is obviously the big focus and reason I have added many more shares)...
It all comes down to the scientific rationale about Bucillamine...
Knowing that it is very safe based on its use with arthritis in Japan is amazing, first of all. Safe drugs are good... But essentially, this is what you need to understand: NAC (a different drug) has been shown to clinically attenuate the symptoms of viral respiratory infections (like covid)...
This is primarily due to donation of Thiols... Bucillamine is 16 x more potent as a thiol donor... So based on what we know in lay terms - Bucillamine is an extremely potent and safe thiol donor, which has been shown to help lungs (in animals and humans) fight the virus.
The question is: is it potent enough to reduce hospitalizations and death on those with covid? I say yes. I base my opinion on clinical rationale aforementioned.
If successful this applies to all viral lung infections, not just covid.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM